AHIMA CEO to step down

Linda Kloss, CEO of the American Health Information Management Association (AHIMA) for the past 15 years, has decided to retire from that role on March 31, 2010.

Kloss said she intends to continue her career-long commitment to improving health information and will explore ways she can contribute during the coming months.

The AHIMA board of directors has initiated a national search for her successor.

AHIMA president Vera Rulon said its board of directors will focus on meeting AHIMA's goals while planning for a transition of executive leadership. 

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.